文献速递头颈外科

大型保险索赔数据库中头颈癌与心理健康疾病的关联

Association of Head and Neck Cancer With Mental Health Disorders in a Large Insurance Claims Database.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2019-01-01

这项回顾性队列研究利用MarketScan数据库2005年1月1日至2014年12月31日的数据,纳入52 641例头颈癌患者,分析心理健康疾病(MHD)的患病率及其与生存和复发的潜在关联。结果显示,头颈癌诊断后MHD患病率由诊断前的20.6%升至29.9%,女性及有烟草、酒精使用史的患者诊断后发生MHD的比值显著更高。

要点

  • 头颈癌诊断后MHD患病率升至29.9%,高于诊断前的20.6%。
  • 女性诊断后MHD的校正OR为1.58(95%CI 1.49-1.67)。
  • 有烟草使用史者校正OR为1.42(95%CI 1.34-1.50),有酒精使用史者为1.56(95%CI 1.38-1.76)。

核心结论

  • 头颈癌诊断后MHD患病率由诊断前的20.6%升至29.9%,且高于一般人群。
  • 女性及有烟草和酒精使用史的患者最易被诊断为MHD。
  • 头颈癌患者治疗后MHD患病率较一般人群增高,两者存在关联。

研究设计与样本

  • 回顾性队列研究,数据来自MarketScan数据库2005年1月1日至2014年12月31日的查询数据。
  • 纳入52 641例诊断为头颈癌的患者,要求索引诊断前在数据库中至少12个月且连续入组。
  • 数据分析时间为2017年2月20日至2019年1月22日。

主要发现

  • 纳入分析的52 641例患者平均(SD)年龄为51.31(9.79)岁,男性占58.5%,55至64岁者占46.6%,来自南部者占40.3%。
  • 口腔癌最常见(40.4%),其次为口咽癌(19.2%)和喉癌(15.5%)。
  • 与口腔癌相比,气管癌患者MHD患病率的OR显著增高(2.11;95%CI 1.87-2.38)。
  • 头颈癌患者MHD患病率从诊断前的20.6%增至诊断后的29.9%。
  • 诊断后MHD的校正OR:女性1.58(95%CI 1.49-1.67),有烟草使用史者1.42(95%CI 1.34-1.50),有酒精使用史者1.56(95%CI 1.38-1.76)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Although a few studies have shown that mental health disorders (MHDs) are strongly associated with the 5-year survival and recurrence rates in patients with head and neck cancer (HNC), none have been replicated in a large-scale study. OBJECTIVE: To describe the prevalence of MHDs in patients with HNC and the potential associations with survival and recurrence using a large insurance claims database. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study assessed data queried from the MarketScan database from January 1, 2005, through December 31, 2014, for 52 641 patients with a diagnosis of HNC. To exclude patients with a preexisting HNC diagnosis or those with incomplete data, patients were included if they were in the database for at least 12 months before the index diagnosis and continuously enrolled. Data were analyzed from February 20, 2017, through January 22, 2019. MAIN OUTCOMES AND MEASURES: To compare the frequency of MHDs before and after diagnosis of HNC, χ2 tests for independence were used. Adjusted adds ratios (aORs) were obtained using multivariable logistic regression by comparing the prevalence of MHDs in patients with oral cavity cancer and those with other cancer sites in the head and neck. RESULTS: Among the 52 641 patients included in the analysis (mean [SD] age, 51.31 [9.79] years), men (58.5%), patients aged 55 to 64 years (46.6%), and those from the South (40.3%) were most commonly affected by HNC. Oral cavity cancers (40.4%) were the most common type, followed by cancers of the oropharynx (19.2%) and larynx (15.5%). Of the various cancer sites, the OR for MHD prevalence was significantly increased in patients with cancers of the trachea compared with the oral cavity (2.11; 95% CI, 1.87-2.38). The prevalence of MHDs in patients with HNC increased to 29.9% compared with 20.6% before the cancer diagnosis. Specifically, women (adjusted OR, 1.58; 95% CI, 1.49-1.67) and patients with a history of tobacco use (adjusted OR, 1.42; 95% CI, 1.34-1.50) and alcohol use (adjusted OR, 1.56; 95% CI, 1.38-1.76) had significantly higher odds of MHDs after the diagnosis of HNC. CONCLUSIONS AND RELEVANCE: Although the baseline MHD prevalence of 20.6% before the cancer diagnosis was close to the national average (17.9% according to the National Survey on Drug Use and Health), results of this study showed that it increased to 29.9% after the cancer diagnosis. Women and patients with a history of tobacco and alcohol use were most susceptible to being diagnosed with an MHD. There is an association between patients with HNC and an increased prevalence of MHDs after treatment compared with the general population.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Lee JH, Ba D, Liu G, et al. Association of Head and Neck Cancer With Mental Health Disorders in a Large Insurance Claims Database. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 30816930. doi:10.1001/jamaoto.2018.4512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。